Confirmation hearing for Alex Azar, Trump’s HHS pick, scheduled for Jan. 9

Alex Azar, President Donald Trump’s nominee for secretary of HHS, is scheduled for a confirmation hearing before the Senate Finance Committee Jan. 9.

Advertisement

Mr. Azar previously served as a deputy secretary at HHS and as president of Eli Lilly’s U.S. division.

“Mr. Azar has demonstrated that he has what it takes to lead the Department of Health and Human Services and that he will tackle the challenges facing the American healthcare system head-on,” said Sen. Orrin Hatch, R-Utah, chairman of the Senate Finance Committee. “Next week’s hearing will give finance committee members a firsthand opportunity to hear from Mr. Azar about his plans to help mitigate Obamacare’s corrosive effects, while ensuring Medicare and Medicaid are strengthened and maintained.”

More articles on leadership and management:

Dr. Anthony Tersigni: Alex Azar would serve the country well as the next HHS secretary
CVS CEO Larry Merlo’s biggest challenge in 27-year run with company? Aetna takeover, analysts say
5 actions Trump can take to undermine the ACA in 2018

At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Leadership & Management

Advertisement

Comments are closed.